With more young people infected with the new coronavirus than ever before, doctors are beginning to notice that younger patients tend to experience slightly different symptoms than older patients,media BGR reported. Fever has long been the most common symptom in patients with new crowns, while young adults under the age of 35 are more likely to develop symptoms such as abdominal pain and headaches.
Dr William Schaffner, professor of infectious diseases at Vanderbilt University, said: “The spectrum of symptoms is expanding, so young people are often a little surprised and without fever, and this abdominal pain seems to affect them more.” “Doctors see other COVID-19 symptoms more frequently in young patients, including severe migraines, nausea and diarrhea.
Currently, the U.S. Centers for Disease Control and Prevention (CDC) lists the following SYMPTOMs of COVID-19:
Fever or chills.
Shortness of breath or difficulty breathing.
Muscle or body pain.
A new loss of taste or sense of smell.
A sore throat.
Nasal congestion or runny nose.
Nausea or vomiting.
These symptoms often occur about 2-14 days after initial exposure to the virus, the CDC said. For people over 34, the most common symptoms are still cough, fever, shortness of breath, fatigue and confusion. It is also worth noting that patients with new crowns who often exhibit the most severe symptoms often have potential comorbidities, such as chronic heart disease, diabetes, or chronic lung disease. Previous studies have also found that smokers are more than 14 percent more likely than nonsmokers to end up with severe new coronary symptoms.
Meanwhile, the race to develop a new crown vaccine is still under way. While there is no guarantee, Dr. Anthony Fauci, a top U.S. infectious disease expert, says an effective vaccine could arrive as early as the end of 2020. So far, Moderna’s Phase 1 trial of its potential coronavirus vaccine found that all 45 volunteers who took the vaccine produced new coronaal antibodies. What’s more, none of the volunteers had serious side effects. A more comprehensive trial program involving 30,000 Americans will begin later this month.